ASHLEY SKINNER: Open Payments
NPI 1841866225 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 78 payments from 20 companies in 2025. Trend: 2023 $701 · 2024 $905 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 24 | $287 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $172 |
| Insmed, Inc. | 6 | $143 |
| GENZYME CORPORATION | 8 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Amgen Inc. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| Davol Inc. | 2 | $51 |
| Viatris Specialty LLC | 2 | $43 |
Products named: NUCALA, Arikayce, TEZSPIRE, DUPIXENT, OFEV, GLASSIA, INGREZZA, ARISTA.
Industry payments across GA — which companies pay providers there.
